International Edition
Latest News
Health

Anthropic Raises $93.5 Billion in Nasdaq IPO During Tech Sell-Off

Anthropic, the developer of the AI model Claude, completed its Nasdaq initial public offering on Thursday, raising $93.5 billion. The listing arrived during a week of significant volatility for the technology sector, as the broader venture capital market…

Anthropic Raises $93.5 Billion in Nasdaq IPO During Tech Sell-Off

Anthropic, the developer of the AI model Claude, completed its Nasdaq initial public offering on Thursday, raising $93.5 billion.

The listing arrived during a week of significant volatility for the technology sector, as the broader venture capital market continues to seek liquidity events.

According to a press release, the company finalized its market debut by selling 1,127,000,000 Class A shares at a price of $83.00 each. This total includes the full exercise of an option for underwriters to purchase an additional 147,000,000 shares. Of the shares sold, roughly 1.1 billion were issued by Anthropic, while approximately 23.6 million were sold by existing shareholders.

The market entry of the AI firm represents a significant shift in the venture capital landscape, where listings had slowed considerably in recent years. Jay Ritter, a professor emeritus at the University of Florida, noted via briefia.fr that venture-backed IPOs generated $73 billion in 2021, a figure that dropped to a total of $39 billion over the subsequent four years. The number of newly listed technology companies also declined from 126 in 2021 to 34 in 2025, briefia.fr reported.

“It is the most important event that venture capital has ever seen,” Ben Narasin, founding partner of Tenacity Venture Capital, told briefia.fr.

Narasin, who did not invest in the company, noted the scale of the transition for a sector that had previously favored private funding over public market exposure.

Beyond the IPO, Anthropic secured an additional $26 billion through a private placement of Class N shares, also priced at $83.00 per share, as reported by a press release. These shares were purchased by a group including Advanced Micro Devices, Broadcom, Google, Micron Technology, Microsoft, Nvidia, and TSMC Partners.

When combined with the IPO proceeds, the total gross funding reached approximately $119.5 billion before accounting for underwriting fees and other transaction costs.

The debut occurred as the Nasdaq faced its most difficult week since the onset of the COVID-19 pandemic in 2020, dropping 10% over five trading days, according to briefia.fr.

Shares of Anthropic opened at $111.50 on Thursday, closing the first session up 17% with a market capitalization of $1.8 trillion. By Friday, the stock finished at $88.91, resulting in a fully diluted market capitalization of $1.6 trillion.

Entity Capitalization or Value
Anthropic (Friday close) $1.6 trillion
Venture-backed IPOs (2021) $73 billion

Investors are now evaluating whether Anthropic’s stock will mirror the performance of hardware-focused AI firms or follow a distinct trajectory. The company, which had struggled to generate revenue just a few years ago, remains heavily dependent on advanced chips, memory, and data center infrastructure. The firm has previously disclosed receiving $141 billion in private capital through September, briefia.fr reported.

Anthropic, a public benefit corporation founded in January 2021, has established its business model around Claude, a series of proprietary large language models available through an online chatbot, an API, and specialized agent harnesses such as Claude Code.

The firm monetizes these products across four distinct tiers—Fable, Opus, Sonnet, and Haiku—while securing high-value contracts, including a $200 million, two-year agreement signed in July 2025 with the US Department of Defense to integrate its technology into classified intelligence networks.

These commercial efforts, combined with strategic partnerships with major cloud providers, have enabled the company to scale its operations into a $1.6 trillion entity capable of securing massive capital infusions from global technology leaders.

About the author: Health Desk

Health Desk at Archynewsy.